FIELD: medicine, pharmaceutics.
SUBSTANCE: the suggested composition includes therapeutically efficient quantity of para-aminosalicylic acid (PASA) as an active substance and target additives as sorbitol, polyvinyl pyrrolidone, salt of stearic acid, talc and citric acid. Pharmaceutical composition is designed as tablets covered with a membrane. The latter contains either "Acryl-iz" of Calarcon firm or composition consisting of copolymer of methacrylic acid with ethylacrylate, titanium dioxide, talc, propylene glycol and iron oxide. The suggested PASA-based antitubercular preparation meets all normative requirements of the State Pharmacopoeia, XI publication and has expiry terms of 2 yr.
EFFECT: higher efficiency of application.
6 cl, 3 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2436580C1 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2009 |
|
RU2424808C2 |
PHARMACEUTICAL COMPOSITION WITH ANTI-TUBERSULOSIS ACTION | 2009 |
|
RU2420288C1 |
COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2417087C2 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2422145C2 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DIABETES MELLITUS (VARIANTS) | 2003 |
|
RU2241449C1 |
MEDICATION FOR TUBERCULOSIS TREATMENT | 2009 |
|
RU2405554C1 |
ANTITUBERCULOSIS PHARMACEUTICAL COMPOSITION CONTAINING THIOACETAZONE | 2015 |
|
RU2627611C2 |
Authors
Dates
2005-03-27—Published
2004-02-09—Filed